| Literature DB >> 30194446 |
Jaakko K Sarin1,2, Nikae C R Te Moller3, Irina A D Mancini3, Harold Brommer3, Jetze Visser4, Jos Malda3,4, P René van Weeren3, Isaac O Afara5, Juha Töyräs5,6.
Abstract
Arthroscopic assessment of articular tissues is highly subjective and poorly reproducible. To ensure optimal patient care, quantitative techniques (e.g., near infrared spectroscopy (NIRS)) could substantially enhance arthroscopic diagnosis of initial signs of post-traumatic osteoarthritis (PTOA). Here, we demonstrate, for the first time, the potential of arthroscopic NIRS to simultaneously monitor progressive degeneration of cartilage and subchondral bone in vivo in Shetland ponies undergoing different experimental cartilage repair procedures. Osteochondral tissues adjacent to the repair sites were evaluated using an arthroscopic NIRS probe and significant (p < 0.05) degenerative changes were observed in the tissue properties when compared with tissues from healthy joints. Artificial neural networks (ANN) enabled reliable (ρ = 0.63-0.87, NMRSE = 8.5-17.2%, RPIQ = 1.93-3.03) estimation of articular cartilage biomechanical properties, subchondral bone plate thickness and bone mineral density (BMD), and subchondral trabecular bone thickness, bone volume fraction (BV), BMD, and structure model index (SMI) from in vitro spectral data. The trained ANNs also reliably predicted the properties of an independent in vitro test group (ρ = 0.54-0.91, NMRSE = 5.9-17.6%, RPIQ = 1.68-3.36). However, predictions based on arthroscopic NIR spectra were less reliable (ρ = 0.27-0.74, NMRSE = 14.5-24.0%, RPIQ = 1.35-1.70), possibly due to errors introduced during arthroscopic spectral acquisition. Adaptation of NIRS could address the limitations of conventional arthroscopy through quantitative assessment of lesion severity and extent, thereby enhancing detection of initial signs of PTOA. This would be of high clinical significance, for example, when conducting orthopaedic repair surgeries.Entities:
Mesh:
Year: 2018 PMID: 30194446 PMCID: PMC6128946 DOI: 10.1038/s41598-018-31670-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The novel fibre optic probe in an equine knee joint in vivo (a) with the probe tip in contact with cartilage surface (inset). Locations of NIRS measurements conducted in vivo during arthroscopy and in vitro in the laboratory (b). Comparison of average smoothed (c) and first derivative pre-processed (d, not used for modelling) spectra collected in vivo and in vitro with two separate spectrometers to cover the wide spectral region. NIRS measurement locations indicated with white and black dots were subjected to biomechanical and micro-CT reference measurements (b). For the red dots, values of reference parameters were only predicted based on ANN models. In subfigure (c), calculation of area between a two-point linear fit and measured spectrum was applied to detect outlier spectra. In subfigure (d), the 1st derivative spectra (not used for analysis) highlight the contribution of light from the conventional arthroscope at the spectral region of 0.42–0.75 µm.
Figure 2Optical coherence tomography (OCT) images from 3 locations, including cartilage thickness (a–c) along with corresponding micro-CT images of the underlying subchondral bone plate and subchondral trabecular bone (d–f). Subchondral plate thickness, bone volume fraction (BV), and bone mineral density (BMD) (d–f, top-right corner), and trabecular bone thickness, BV, BMD, and structural model index (SMI) (d–f, bottom-right corner) are presented. In addition, the optimal wavelengths for ANN models (Model 1) are presented (g–i). The width of each bar is 10 wavelengths (i.e., maximum number of variables in subfigure (g) is 20, as two variables are displayed). The dashed line indicates a separation of the spectral measurement regions of the two spectrometers.
Figure 3Boxplots for experiment (post-traumatic) and control (healthy) groups with median (red line), quartiles (25% and 75%), and outliers (red cross) of in vitro measured (white bars) cartilage equilibrium modulus (a), dynamic modulus (b), and subchondral bone plate BMD (c) for the four locations at increasing distances from the lesion. Additionally, predictions based on the optimal model (Model 1) for in vitro and arthroscopic NIRS measurements are presented (grey and black bars, respectively). For each location, experiment and control groups had 12–14 and 6 measurements, respectively.
Two-tailed Spearman (ρ) correlation coefficients between the measured and predicted values of cartilage: equilibrium (E) and dynamic moduli (E), subchondral bone plate: bone volume fraction (BV), bone mineral density (BMD), and thickness, and trabecular bone: BV, BMD, thickness, and structure model index (SMI).
| Mean (95% Confidence interval) | Spectral region (µm) | Number of variables |
| Arthroscopic | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||||||
|
| NRMSE | RPIQ |
| NRMSE | RPIQ |
|
| NRMSE | RPIQ | |||||
| Cartilage | 579 (506, 652) | 0.75–1.90* | 74 | 0.873 | 8.5% | 3.14 | 0.890 | 5.9% | 3.36 | 0.736 | <0.0001 | 14.5% | 1.46 | |
| 0.75–1.90 | 85 | 0.874 | 9.0% | 2.96 | 0.835 | 7.0% | 2.85 | 0.466 | <0.0001 | 23.5% | 0.90 | |||
| 0.40–1.90 | 52 | 0.699 | 17.6% | 1.51 | 0.876 | 7.2% | 2.76 | — | — | — | — | |||
| 7.25 (6.61, 7.89) | 0.75–1.90* | 214 | 0.775 | 16.5% | 2.38 | 0.910 | 14.0% | 3.16 | 0.692 | <0.0001 | 19.7% | 1.70 | ||
| 0.75–1.90 | 61 | 0.793 | 15.8% | 2.50 | 0.943 | 12.2% | 3.63 | 0.544 | <0.0001 | 21.8% | 1.53 | |||
| 0.40–1.90 | 133 | 0.853 | 12.4% | 3.19 | 0.963 | 7.3% | 6.07 | — | — | — | — | |||
| Subchondral bone plate | BV (%) | 98.4 (98.1, 98.7) | 0.75–1.90* | 133 | 0.689 | 7.1% | 1.34 | 0.582 | 23.2% | 1.30 | 0.384 | <0.0001 | 10.4% | 0.81 |
| 0.75–1.90 | 171 | 0.790 | 4.7% | 2.03 | 0.867 | 9.5% | 3.17 | 0.358 | 0.0002 | 18.5% | 0.46 | |||
| 0.40–1.90 | 110 | 0.737 | 3.8% | 2.45 | 0.697 | 10.3% | 2.93 | — | — | — | — | |||
| BMD (g/cm3) | 1.00 (0.99, 1.02) | 0.75–1.90* | 39 | 0.632 | 17.2% | 2.18 | 0.539 | 17.6% | 1.68 | 0.268 | 0.0063 | 24.0% | 1.61 | |
| 0.75–1.90 | 88 | 0.725 | 15.0% | 2.49 | 0.732 | 16.0% | 1.85 | −0.179 | 0.07 | 31.3% | 1.23 | |||
| 0.40–1.90 | 18 | 0.544 | 18.3% | 2.04 | 0.757 | 15.6% | 1.90 | — | — | — | — | |||
| Thick. (µm) | 174 (166, 182) | 0.75–1.90* | 27 | 0.729 | 14.0% | 2.45 | 0.896 | 9.9% | 2.86 | 0.507 | <0.0001 | 22.0% | 1.45 | |
| 0.75–1.90 | 182 | 0.750 | 18.9% | 1.81 | 0.950 | 12.0% | 2.36 | 0.364 | 0.0002 | 32.8% | 0.97 | |||
| 0.40–1.90 | 143 | 0.794 | 18.5% | 1.85 | 0.896 | 12.9% | 2.19 | — | — | — | — | |||
| Trabecular bone | BV (%) | 30.5 (29.8, 31.3) | 0.75–1.90* | 56 | 0.781 | 11.2% | 2.26 | 0.871 | 12.7% | 2.15 | 0.547 | <0.0001 | 20.8% | 1.46 |
| 0.75–1.90 | 28 | 0.703 | 12.4% | 2.04 | 0.911 | 10.5% | 2.60 | 0.325 | 0.0008 | 32.3% | 0.94 | |||
| 0.40–1.90 | 39 | 0.742 | 12.3% | 2.06 | 0.949 | 10.6% | 2.57 | — | — | — | — | |||
| BMD (g/cm3) | 0.247 (0.237, 0.258) | 0.75–1.90* | 69 | 0.735 | 13.2% | 2.08 | 0.856 | 14.7% | 1.89 | 0.346 | 0.0003 | 22.9% | 1.35 | |
| 0.75–1.90 | 103 | 0.739 | 13.3% | 2.06 | 0.795 | 16.0% | 1.73 | 0.266 | 0.0066 | 25.4% | 1.22 | |||
| 0.40–1.90 | 36 | 0.763 | 11.8% | 2.30 | 0.929 | 11.6% | 2.40 | — | — | — | — | |||
| Thick. (µm) | 169 (167, 172) | 0.75–1.90* | 34 | 0.679 | 14.4% | 1.86 | 0.816 | 16.9% | 2.46 | 0.442 | <0.0001 | 17.6% | 1.50 | |
| 0.75–1.90 | 69 | 0.776 | 12.4% | 2.16 | 0.850 | 13.3% | 3.12 | −0.065 | 0.51 | 25.7% | 1.03 | |||
| 0.40–1.90 | 63 | 0.628 | 14.8% | 1.81 | 0.821 | 14.0% | 2.98 | — | — | — | — | |||
| SMI | 0.367 (0.316, 0.417) | 0.75–1.90* | 13 | 0.728 | 11.8% | 2.15 | 0.889 | 12.9% | 2.59 | 0.465 | <0.0001 | 19.8% | 1.64 | |
| 0.75–1.90 | 104 | 0.844 | 10.6% | 2.38 | 0.906 | 11.1% | 3.02 | 0.217 | 0.028 | 37.0% | 0.88 | |||
| 0.40–1.90 | 52 | 0.825 | 10.9% | 2.33 | 0.886 | 9.9% | 3.40 | — | — | — | — | |||
Calibration and Validation indicates the correlation coefficient for both calibration and validation groups (nine ponies, N = 212), whereas the Test indicates the correlation coefficient for the independent test group (one pony, N = 24). In addition, the normalized root mean square error (NRMSE) and ratio of performance to inter-quartile range (RPIQ) are presented for these groups as well as for the arthroscopic data. The upmost row (*) of each parameter, indicates the model with optimized wavelength selection for arthroscopic predictions (Model 1). For all in vitro correlations, p-values were <0.01.